The most commonly recommended protocol is 2 mg daily via subcutaneous injection for 10 to 12 weeks, followed by a 4 to 6 week rest period
The MHRA has approved specific GLP-1 receptor agonists for weight management (Wegovy and Saxenda) in individuals with a body mass index (BMI) of 30 kg/m or above, or 27 kg/m with weight-related comorbidities, while others are approved only for glycaemic control in type 2 diabetes
When the trigger that caused the shift eases, often weight stabilization or correction of stress and nutrient gaps, the cycle returns to its usual rhythm, and new hairs begin their anagen growth
Discreet Home Delivery Your medication and supplies are shipped directly and discreetly to your address
These dates provide guidelines for expected freshness
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much